{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:12:25Z","timestamp":1790475145109,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Vascular calcification is a major cause of morbidity and mortality in dialysis patients. Human and animal studies indicate that sodium thiosulfate (STS) may prevent the progression of vascular calcifications. The pharmacokinetics of STS in hemodialysis patients has not been investigated yet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>STS was given intravenously to 10 hemodialysis patients on- and off-hemodialysis. Additionally, STS was applied to 9 healthy volunteers once intravenously and once orally. Thiosulfate concentrations were measured by using a specific and sensitive HPLC method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In volunteers and patients, mean endogenous thiosulfate baseline concentrations were 5.5 \u00b1 1.82\n                      <jats:italic toggle=\"yes\">versus<\/jats:italic>\n                      7.1 \u00b1 2.7 \u03bcmol\/L. Renal clearance was high in volunteers (1.86 \u00b1 0.45 ml\/min per kg) and reflected GFR. Nonrenal clearance was slightly, but not significantly, higher in volunteers (2.25 \u00b1 0.32 ml\/min per kg) than in anuric patients (2.04 \u00b1 0.72 ml\/min per kg). Hemodialysis clearance of STS was 2.62 \u00b1 1.01 ml\/min per kg. On the basis of the nonrenal clearance and the thiosulfate steady-state serum concentrations, a mean endogenous thiosulfate generation rate of 14.6 nmol\/min per kg was calculated in patients. After oral application, only 4% of STS was recovered in urine of volunteers, reflecting a low bioavailability of 7.6% (0.8% to 26%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Given the low and variable bioavailability of oral STS, only intravenous STS should be prescribed today. The biologic relevance of the high hemodialysis clearance for the optimal time point of STS dosing awaits clarification of the mechanisms of action of STS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.10241110","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T20:15:06Z","timestamp":1305317706000},"page":"1447-1455","source":"Crossref","is-referenced-by-count":50,"title":["Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers"],"prefix":"10.2215","volume":"6","author":[{"given":"Stefan","family":"Farese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kalicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik E.","family":"Uehlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20230811","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.2215\/CJN.04800709","article-title":"Vascular calcification and ESRD: A hard target","volume":"4","author":"Bhan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-30-20230811","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","article-title":"Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure","volume":"103","author":"Guerin","year":"2001","journal-title":"Circulation"},{"key":"R3-30-20230811","first-page":"1164","article-title":"Acute cyanide poisoning; recovery with sodium thiosulfate therapy","volume":"44","author":"Miller","year":"1951","journal-title":"J Indiana State Med Assoc"},{"key":"R4-30-20230811","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/clpt.1984.53","article-title":"Kinetics of sodium thiosulfate, a cisplatin neutralizer","volume":"35","author":"Shea","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"R5-30-20230811","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0041-008X(85)90163-2","article-title":"Antagonism of cyanide poisoning by chlorpromazine and sodium thiosulfate","volume":"81","author":"Pettersen","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"R6-30-20230811","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1111\/j.1742-4658.2008.06482.x","article-title":"Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria","volume":"275","author":"Hildebrandt","year":"2008","journal-title":"FEBS J"},{"key":"R7-30-20230811","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/ndt\/gfh825","article-title":"Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report","volume":"20","author":"Guerra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R8-30-20230811","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2005.00082.x","article-title":"Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis","volume":"18","author":"Brucculeri","year":"2005","journal-title":"Semin Dial"},{"key":"R9-30-20230811","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00467-006-0387-9","article-title":"Transient severe metastatic calcification in acute renal failure","volume":"22","author":"Landau","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R10-30-20230811","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate","volume":"43","author":"Cicone","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R11-30-20230811","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2215\/CJN.01520506","article-title":"Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults","volume":"1","author":"Araya","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-30-20230811","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/08860220600583781","article-title":"Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis","volume":"28","author":"Mataic","year":"2006","journal-title":"Ren Fail"},{"key":"R13-30-20230811","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ki.2008.455","article-title":"Sodium thiosulfate prevents vascular calcifications in uremic rats","volume":"74","author":"Pasch","year":"2008","journal-title":"Kidney Int"},{"key":"R14-30-20230811","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/ndt\/gfp755","article-title":"Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients","volume":"25","author":"Adirekkiat","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R15-30-20230811","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2009.99","article-title":"Sodium thiosulfate in the treatment of calcific uremic arteriolopathy","volume":"5","author":"Schlieper","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R16-30-20230811","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"73","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"key":"R17-30-20230811","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ki.2008.502","article-title":"Treatment of vascular calcification","volume":"74","author":"O'Neill","year":"2008","journal-title":"Kidney Int"},{"key":"R18-30-20230811","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000441-193412000-00003","article-title":"Comparative values of several antidotes in cyanide poisoning","volume":"188","author":"Chen","year":"1934","journal-title":"Am J Med Sci"},{"key":"R19-30-20230811","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0003-2697(81)90498-X","article-title":"Analysis of biological thiols: Derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography","volume":"114","author":"Newton","year":"1981","journal-title":"Anal Biochem"},{"key":"R20-30-20230811","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00699228","article-title":"Oxgen dependent sulfide detoxification in the lugworm Arenicol marina","volume":"118","author":"V\u00f6lkel","year":"1994","journal-title":"Mar Biol"},{"key":"R21-30-20230811","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jps.2600680845","article-title":"Noncompartmental determination of the steady-state volume of distribution","volume":"68","author":"Benet","year":"1979","journal-title":"J Pharm Sci"},{"key":"R22-30-20230811","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jps.2600710432","article-title":"General derivation of the equation for time to reach a certain fraction of steady state","volume":"71","author":"Perrier","year":"1982","journal-title":"J Pharm Sci"},{"key":"R23-30-20230811","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0272-6386(84)80081-5","article-title":"Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome","volume":"3","author":"Frey","year":"1984","journal-title":"Am J Kidney Dis"},{"key":"R24-30-20230811","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2013a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"R25-30-20230811","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose\u2013an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"R26-30-20230811","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/bjs.6454","article-title":"Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis","volume":"96","author":"Rowan","year":"2009","journal-title":"Br J Surg"},{"key":"R27-30-20230811","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/ajplegacy.1960.198.3.586","article-title":"Inorganic sulfate and thiosulfate: Transport and competition in renal tubules of the dog","volume":"198","author":"Berglund","year":"1960","journal-title":"Am J Physiol"},{"key":"R28-30-20230811","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11255-004-8784-0","article-title":"Gestational urinary hyperthiosulfaturia protects hypercalciuric normal pregnant women from nephrolithiasis","volume":"36","author":"Yatzidis","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"R29-30-20230811","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2008070754","article-title":"Thiosulfate reduces calcium phosphate nephrolithiasis","volume":"20","author":"Asplin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R30-30-20230811","first-page":"820","article-title":"Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients","volume":"19","author":"Musso","year":"2008","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R31-30-20230811","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/ndt\/16.12.2443","article-title":"Does long-term administration of sodium thiosulphate inhibit progression to renal failure in nephrocalcinosis?","volume":"16","author":"Agroyannis","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R32-30-20230811","first-page":"229","article-title":"The renal clearance of thiosulfate in man","volume":"79","author":"Newman","year":"1946","journal-title":"Bull Johns Hopkins Hosp"},{"key":"R33-30-20230811","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1152\/ajplegacy.1946.146.3.348","article-title":"The renal clearance of thiosulfate with observations on its volume distribution","volume":"146","author":"Gilman","year":"1946","journal-title":"Am J Physiol"},{"key":"R34-30-20230811","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3181\/00379727-170-41430","article-title":"Thiosulfate pharmacokinetics in normal and anuric dogs","volume":"170","author":"Braverman","year":"1982","journal-title":"Proc Soc Exp Biol Med"},{"key":"R35-30-20230811","first-page":"133","article-title":"Hepatic metabolism of aminopyrine in patients with chronic renal failure","volume":"54","author":"Scherrer","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"R36-30-20230811","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.29.4.614","article-title":"Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin","volume":"29","author":"Horber","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-30-20230811","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.1840090416","article-title":"Impaired liver function in stable renal allograft recipients","volume":"9","author":"Frey","year":"1989","journal-title":"Hepatology"},{"key":"R38-30-20230811","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00003088-198409030-00005","article-title":"Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate","volume":"9","author":"Schulz","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"R39-30-20230811","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/0006-2952(80)90346-9","article-title":"Oxidation of sodium sulphide by rat liver, lungs and kidney","volume":"29","author":"Bartholomew","year":"1980","journal-title":"Biochem Pharmacol"},{"key":"R40-30-20230811","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/1891007a0","article-title":"The metabolic state of thiosulphate","volume":"189","author":"Szczepkowski","year":"1961","journal-title":"Nature"},{"key":"R41-30-20230811","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/ki.1991.131","article-title":"Pharmacokinetic determinants of cyclosporine and prednisone in renal transplant patients","volume":"39","author":"Frey","year":"1991","journal-title":"Kidney Int"},{"key":"R42-30-20230811","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2840-4-4","article-title":"Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: The emerging role of sodium thiosulfate","volume":"4","author":"Hayden","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"R43-30-20230811","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report","volume":"5","author":"Schurgers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R44-30-20230811","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ki.5001996","article-title":"Novel insights into vascular calcification","volume":"105","author":"Ketteler","year":"2006","journal-title":"Kidney Int"},{"key":"R45-30-20230811","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201106000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:49Z","timestamp":1786369249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201106000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10241110","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}